Relationship between peripheral serum NLRP3, HMGB1 levels and ischemia-reperfusion injury in patients with acute ST segment elevation myocardial infarction after PCI
Time：2022-07-21 Source：
参考文献(References)：
[1]中国医师协会急诊医师分会，国家卫健委能力建设与继续教育中心急诊学专家委员会，中国医疗保健国际交流促进会急诊急救分会．急性冠脉综合征急诊快速诊治指南（2019)[J]．中国急救医学，2019,28(4):421-428.DOI:10.3969/j.issn.1002-1949.2019.04.001．Emergency
Physician Branch of Chinese Medical Doctor Association,Emergency
Medicine Expert Committee of National Health and Medical Commission
Capacity Building and Continuing Education Center,Emergency Emergency
Branch of China Association for the Promotion of International Exchange
of Medical Care.Guidelines for the rapid diagnosis and treatment of
acute coronary syndrome (2019)[J].Chin J Emerg Med,2019,28
(4):421-428.DOI:10.3969/j.issn.1002-1949.2019.04.001．
[2]中华医学会心血管病学分会介入心脏病学组，中国医师协会心血管内科医师分会血栓防治专业委员会，中华心血管病杂志编辑委员会．中国经皮冠状动脉介入治疗指南（2016)[J]．中华心血管病杂志，2016,44
(5):382-400.DOI:10.3760/cma.j.issn.0253-3758.2016.05.006．Interventional
Cardiology Group of Cardiovascular Branch of Chinese Medical
Association,Professional Committee of Thrombosis Prevention and
Treatment of Cardiovascular Physicians Branch of Chinese Medical Doctor
Association,Editorial Board of Chinese Journal of Cardiovascular
Disease.Guidelines for percutaneous coronary intervention in China
(2016)[J].Chin J Cardiol,2016,44
(5):382-400.DOI:10.3760/cma.j.issn.0253-3758.2016.05.006．
[3]Kakavand
H,Aghakouchakzadeh M,Coons JC,et al.Pharmacologic prevention of
myocardial ischemia-reperfusion injury in patients with acute coronary
syndrome undergoing percutaneous coronary intervention[J].J Cardiovasc
Pharmacol,2021,77 (4):430-449.DOI:10.1097/FJC.0000000000000980．
[4]Xu
W,Zhang K,Zhang Y,et al.Downregulation of DEC1 by RNA interference
attenuates ischemia/reperfusion-induced myocardial inflammation by
inhibiting the TLR4/NF-κB signaling pathway[J].Exp Ther Med,2020,20
(1):343-350.DOI:10.3892/etm.2020.8706．
[5]刘成兴，林吉斌，李大主．心肌缺血再灌注损伤中细胞焦亡的研究进展[J]．国际免疫学杂志，2021,44
(1):71-75.DOI:10.3760/cma.j.issn.1673-4394.2021.01.012．Liu CX,Lin JB,Li
DZ.Research progress of pyroptosis in myocardial ischemia-reperfusion
injury[J].Natl Med J
China,2021,44(1):71-75.DOI:10.3760/cma.j.issn.1673-4394.2021.01.012．
[6]Wang
Y,Liu X,Shi H,et al.NLRP3 inflammasome,an immune-inflammatory target in
pathogenesis and treatment of cardiovascular diseases[J].Clin Transl
Med,2020,10 (1):91-106.DOI:10.1002/ctm2.13．
[7]Ge Y,Huang
M,Yao YM.The effect and regulatory mechanism of high mobility group
box-1 protein on immune cells in inflammatory diseases[J].Cells,2021,10
(5):1044.DOI:10.3390/cells10051044．
[8]萧闵，向晶晶，王威，等．金香丹抑制NLRP3/IL-1β/Caspase-1信号通路缓解大鼠心肌缺血再灌注损伤[J]．中国实验方剂学杂志，2021,27(20):87-94.DOI:10.13422/j.cnki.syfjx.20212038．Xiao
M,Xiang JJ,Wang W,et al.Jinxiangdan inhibits NLRP3/IL-13/Caspase-1
pathway to alleviate myocardial ischemia-reperfusion injury in
rats[J].Chinese Journal of Experimental
Formulas,2021,27(20):87-94.DOI:10.13422/j.cnki.syfjx.20212038．
[9]黎真真，陈飞任，吴红发，等．异丙酚对心肌缺血再灌注损伤大鼠模型Toll样受体4及高迁移率族蛋白1表达的影响[J]．实用临床医药杂志，2021,25(3):13-18.DOI:10.7619/jcmp.20201602．Li
ZZ,Chen FR,Wu HF,et al.Influence of propofol on expressions of
Toll-like receptor 4 and high mobility group box 1 in the rat model of
myocardial ischemia reperfusion injury[J].Journal of Practical Clinical
Medicine,2021,25(3):13-18.DOI:10.7619/jcmp.20201602．
[10]中华医学会，中华医学会杂志社，中华医学会全科医学分会，等．ST段抬高型心肌梗死基层诊疗指南（2019年）[J]．中华全科医师杂志，2020,47(12):766-783.DOI:10.3760/cma.j.cn114798-20200904-00961．Chinese
Medical Association,Chinese Medical Journals Publishing House,Chinese
Society of General Practice,et al.Guideline for primary care of
ST-segment elevation myocardial infarction(2019)[J].Chin J Gen
Pract,2020,47 (12):766-783.DOI:10.3760/cma.j.cn114798-20200904-00961．
[11]张英，王亚柱，张皓然，等．心肌缺血再灌注损伤不同表现形式的临床研究[J]．中国医药导报，2019,16(23):64-68．Zhang
Y,Wang YZ,Zhang HR,et al.Clinical study on different manifestations of
myocardial ischemia-reperfusion injury[J].China Medical
Herald,2019,16(23):64-68．
[12]Bellis A,Di Gioia G,Mauro
C,et al.Reducing cardiac injury during ST-elevation myocardial
infarction:A reasoned approach to a multitarget therapeutic
strategy[J].J Clin Med,2021,10 (13):2968.DOI:10.3390/jcm10132968．
[13]Thompson
J,Maceyka M,Chen Q.Targeting ER stress and calpain activation to
reverse age-dependent mitochondrial damage in the heart[J].Mech Ageing
Dev,2020,192:111380.DOI:10.1016/j.mad.2020.111380．
[14]Zhao
K,An R,Xiang Q,et al.Acid-sensing ion channels regulate nucleus
pulposus cell inflammation and pyroptosis via the NLRP3 inflammasome in
intervertebral disc degeneration[J/OL].Cell
Prolif,2021,54(1):e12941.DOI:10.1111/cpr.12941．
[15]Bian
Y,Li X,Pang P,et al.Kanglexin,a novel anthraquinone compound,protects
against myocardial ischemic injury in mice by suppressing NLRP3 and
pyroptosis[J].Acta Pharmacol
Sin,2020,41(3):319-326.DOI:10.1038/s41401-019-0307-8．
[16]石同欢，孔彬，帅维，等．中性/淋巴细胞比值、超敏肌钙蛋白I联合CHA2DS2-VASC评分与非ST段抬高型心肌梗死患者罪犯血管完全闭塞的相关性[J]．疑难病杂志，2021,20
(1):2-6,12.DOI:10.3969/j.issn.1671-6450.2021.01.001．Shi TH,Kong B,Shuai
W,et al.Correlation between neutral/lymphocyte ratio,high-sensitivity
troponin I combined with CHA2 DS2-VASC score and complete vascular
occlusion of criminals in patients with non-ST-segment elevation
myocardial infarction[J].Chin J Diffic and Compl Cas,2021,20
(1):2-6,12.DOI:10.3969/j.issn.1671-6450.2021.01.001．
[17]Mo
G,Liu X,Zhong Y,et al.IP3R1 regulates Ca2+transport and pyroptosis
through the NLRP3/Caspase-1 pathway in myocardial ischemia/reperfusion
injury[J].Cell Death Discov,2021,7(1):31.DOI:10.1038/s41420-021-00404-4．
[18]彭夫松，王本荣，杨磊磊，等．不同时间血运重建对老年急性心肌梗死患者心功能及不良心脏事件的影响[J]．疑难病杂志，2020,19(6):574-577.DOI:10.3969/j.issn.1671-6450.2020.06.009．Peng
FS,Wang BR,Yang LL,et al.Effects of different time of revascularization
on cardiac function and adverse cardiac events in elderly patients with
a-cute myocardial infarction[J].Chin J Diffic and Compl
Cas,2020,19(6):574-577.DOI:10.3969/j.issn.1671-6450.2020.06.009．
[19]Fu
HR,Li XS,Zhang YH,et al.Visnagin ameliorates myocardial
ischemia/reperfusion injury through the promotion of autophagy and the
inhibition of apoptosis[J].Eur J Histochem,2020,64
(S2):3131.DOI:10.4081/ejh.2020.3131．
[20]肖政，黄鹤．高迁移率族蛋白B1在心肌缺血再灌注损伤中的双重作用[J]．安徽医药，2021,25(12):2338-2341.DOI:10.3969/j.issn.1009-6469.2021.12.002．Xiao
Z,Huang H.Dual function of high-mobility group box-1 in myocardial
ischemia/reperfusion injury[J].Anhui Medicine,2021,25(12):2338-2341．
[21]Xing
J,Liu J,Liu J,et al.miR-129-5p ameliorates ischemia-reperfusion injury
by targeting HMGB1 in myocardium[J].Gen Physiol
Biophys,2020,39(5):461-470.DOI:10.4149/gpb_2020021．
[22]Sun
G,Shen JF,Wei XF,et al.Circular RNA Foxo3 relieves myocardial
ischemia/reperfusion injury by suppressing autophagy via inhibiting
HMGB1 by repressing KAT7 in myocardial infarction[J].J Inflamm
Res,2021,14:6397-6407.DOI:10.2147/JIR.S339133.
